These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24709373)
1. Drug company drops case after EMA agrees to redactions in some documents to be published. Dyer C BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373 [No Abstract] [Full Text] [Related]
2. Europe's drug regulator opens vaults of clinical-trials data. Abbott A Nature; 2016 Oct; 538(7626):440. PubMed ID: 27786232 [No Abstract] [Full Text] [Related]
3. AbbVie considers harms to be commercially confidential information: sign a petition. Gøtzsche PC BMJ; 2013 Dec; 347():f7569. PubMed ID: 24366821 [No Abstract] [Full Text] [Related]
4. European ombudsman questions European Medicines Agency over AbbVie redactions. Watson R BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123 [No Abstract] [Full Text] [Related]
5. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies. Cohen K; Cormier JW; Davar MV J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261 [No Abstract] [Full Text] [Related]
6. Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents. Doshi P JAMA Intern Med; 2013 Nov; 173(21):2009-11. PubMed ID: 23959623 [No Abstract] [Full Text] [Related]
7. NICE is urged to make drug companies supply all trial data. O'Dowd A BMJ; 2012 Dec; 345():e8294. PubMed ID: 23223692 [No Abstract] [Full Text] [Related]
8. Drug companies should release data from all trials of licensed drugs, say MPs. Hawkes N BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880 [No Abstract] [Full Text] [Related]
9. Drug-company data vaults to be opened. Cressey D Nature; 2013 Mar; 495(7442):419-20. PubMed ID: 23538802 [No Abstract] [Full Text] [Related]
10. Neonatal drug trials: impact of EU and US paediatric regulations. Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777 [No Abstract] [Full Text] [Related]
11. Putting GlaxoSmithKline to the test over paroxetine. Doshi P BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673 [No Abstract] [Full Text] [Related]
12. Glaxo agrees to post results of drug trials on web site. Harris G N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364 [No Abstract] [Full Text] [Related]
13. Transparency campaigners welcome new rules for clinical trials in Europe. Kmietowicz Z BMJ; 2014 Apr; 348():g2579. PubMed ID: 24699321 [No Abstract] [Full Text] [Related]
14. European regulator is ordered not to release clinical study documents. Kmietowicz Z BMJ; 2013 May; 346():f2846. PubMed ID: 23641049 [No Abstract] [Full Text] [Related]
15. European regulator is urged to release data on drugs approved in past 10 years. Kmietowicz Z BMJ; 2013 Sep; 347():f5905. PubMed ID: 24081901 [No Abstract] [Full Text] [Related]
16. Direct-to-consumer drug information in Europe. Ager B Lancet; 2007 Mar; 369(9564):822. PubMed ID: 17350444 [No Abstract] [Full Text] [Related]
17. EU directive on clinical trials penalizes small sponsors. Meldolesi A Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186 [No Abstract] [Full Text] [Related]
18. [Public access to the results of clinical trials with drugs: is this enough for practicing physicians and patients?]. Dal-Ré R Med Clin (Barc); 2014 Aug; 143(4):180-4. PubMed ID: 24667112 [No Abstract] [Full Text] [Related]
19. The European Medicines Agency's plans for sharing data from clinical trials. Groves T; Godlee F BMJ; 2013 May; 346():f2961. PubMed ID: 23657192 [No Abstract] [Full Text] [Related]
20. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related] [Next] [New Search]